Author:
Gerlach Manfred,Bartoszyk Gerd D.,Riederer Peter,Dean Olivia,van den Buuse Maarten
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference54 articles.
1. Ahlenius S, Henriksson I, Magnusson O, Salmi P (1999) In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100, 635 and (S)-(−)-UH-301 at rat brain monoamine receptors. Eur Neuropsychopharmacol 9:15–19
2. Antonelli T, Fuxe K, Tomasini MC, Bartoszyk GD, Seyfried CA, Tanganelli S, Ferraro L (2005) Effects of sarizotan on the corticostriatal glutamate pathways. Synapse 58:193–199
3. Arai R, Horiike K, Hasegawa Y (1998) Dopamine-degrading activity of monoamine oxidase in locus coeruleus and dorsal raphe nucleus neurons. A histochemical study in the rat. Neurosci Lett 250:41–44
4. Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ (1998) A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D-3 receptor antagonists (+)-S 14297, nafadotride, GR 103, 691 and U 99194. J Pharmacol Exp Ther 287:187–197
5. Ba MW, Kong M, Ma GZ, Yang HQ, Lu GQ, Chen SD, Liu ZG (2007) Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications. Brain Res 1127:177–184
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献